Floatz logo

Abciximab

Carotid Stenosis

monoclonal_antibodyPhase 1/2Dormant
C
35/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
20/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Carotid Stenosis cohort.

Asset / SponsorPhaseRating
Plavix
Asan Medical Center
Phase 4BB
Lipitor
Columbia University
Phase 4BB
EPHEDRINE, ANHYDROUS
University Hospital, Clermont-Ferrand
Phase 4BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Asan Medical Center
Phase 4BB
Acetylsalicylic Acid
Asan Medical Center
Phase 4BB

View all 26 →

Same molecule, other indications

Abciximab is also rated in:

stroke disorderDormant
CC
Indicative ·
46 / 100
View asset →
brain ischemiaDormant
CC
Indicative ·
42 / 100
View asset →
acute diseaseDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →